BetterLife Pharma (BETRF) Change in Cash (2010 - 2026)

BetterLife Pharma's Change in Cash history runs 17 years deep, the most recent figure standing at $11676.5 for Q2 2026.

• In Q2 2026, Change in Cash rose 53.59% year-over-year to $11676.5; the TTM figure through Apr 2026 stood at $14190.5 (up 104.81% YoY), while the FY2026 annual figure was $3163.3, up 115.38% from the prior year.
• Change in Cash for Q2 2026 stood at $11676.5, up from $2303.4 in the prior quarter.
• The five-year high for Change in Cash was $63.5 billion in Q4 2022, with the low at -$62.5 billion in Q1 2023.
• The 5-year median for Change in Cash is -$3692.7 (2022), against an average of $60.5 million.
• The sharpest annual moves came in 2022 and 2023: Change in Cash jumped 3776622.01% in 2022, then sank 4035323.95% in 2023.
• BetterLife Pharma's Change in Cash stood at $63.5 billion in 2022, then slumped by 100.0% to $23324.0 in 2023, then slumped by 437.93% to -$78817.7 in 2024, then surged by 102.92% to $2303.4 in 2025, then soared by 406.91% to $11676.5 in 2026.
• Business Quant data shows BETRF's Change in Cash at $11676.5 in Q2 2026, $2303.4 in Q3 2025, and $7602.1 in Q2 2025.